Everyone who read the extracts from Michael Schofield’s memoir, published by the Guardian on January 19th, must surely have been moved by the sometimes harrowing description of his daughter Janni who was diagnosed with child-onset schizophrenia aged just 7 years old. Janni is an exception, as schizophrenia generally starts between the ages of 15 and [read the full story…]
NICE publish new evidence summary on psychosis with coexisting substance misuse
The NICE guideline on psychosis with coexisting substance misuse was published in 2011, which means it’s now nearly 3 years out of date. This is because guidelines take many months to produce, so by the time they are published the evidence in them is 1 year old at best. Some NICE guidelines are supplemented by [read the full story…]
NICE evidence summary on the unlicensed and off-label use of melatonin for sleep disorders in children with ADHD
NICE have recently started publishing a series of evidence summaries looking at unlicensed and off-label medicines. The second summary in the series looks at the use of prolonged-release melatonin tablets as a treatment for sleep disorders in children and young people with attention deficit hyperactivity disorder (ADHD). Future mental health summaries include ‘Quetiapine for generalised [read the full story…]
NICE recommends an integrated approach for the care of people with drug use disorders
NICE have published a new quality standard aimed at supporting the recovery for adults with drug use disorders, including opioids, cannabis, stimulants and other drugs. This set of documents on drug use disorders now sits beside the existing NICE quality standards on dementia, depression in adults, alcohol dependence and service user experiences of adult mental [read the full story…]
New QIPP case studies from NICE
If you work in the NHS, public health or social care, you’ve probably heard of QIPP (Quality, Innovation, Productivity and Prevention), but have you heard of the QIPP collection? It’s a website run by NICE that contains: QIPP case studies – examples of how health and social care staff are improving quality and productivity across [read the full story…]
New NICE briefings on inequalities and population health, the Public Health Outcomes Framework and alcohol
NICE have published three new public health briefings for local government on Inequalities and population health, the Public Health Outcomes Framework and Alcohol. These documents are aimed at local authorities and their partner organisations in the health and voluntary sectors, in particular those involved with health and wellbeing boards. Local government is preparing to take [read the full story…]
NICE publish new guidance on the social and emotional wellbeing of vulnerable children under five
These new recommendations from the National Institute for Health and Clinical Excellence (NICE) cover home visits, early education and childcare for vulnerable children. The public health guidance recognises that disadvantage before birth and in a child’s early years can have life-long, negative effects on health and wellbeing. It aims to ensure that both universal and [read the full story…]
NICE publish evidence update on generalised anxiety disorder in adults
NHS Evidence have published an evidence update on generalised anxiety disorder in adults. Evidence updates are summaries of selected high quality evidence that has appeared since the relevant guideline was published, in this case NICE clinical guideline 113 ‘Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care’ [read the full story…]
New NICE guidance to help people stop using traditional South Asian varieties of smokeless tobacco
NICE have published public health guidance and a new care pathway to help people of South Asian origin who are living in England to stop using traditional South Asian varieties of smokeless tobacco. These publications are focused on people with ancestral links to Bangladesh, India, Nepal, Pakistan or Sri Lanka and smokeless tobacco products such [read the full story…]
Psychosis and schizophrenia in children and young people: NICE starts consultation
The two month consultation period for the new NICE guideline on psychosis and schizophrenia in children and young people has now begun. You must be registered as a stakeholder to comment on the guideline and you have until 27th September 2012 to make your views known. The guideline is aimed at clinicians and service commissioners [read the full story…]